Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FY5MB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,033
Award facts
- Contract value 100% obligated
- $34,033.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency has awarded a delivery order valued at $34,033.10 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300 mg pens in 2 ml formulations. This competitively awarded, firm fixed-price delivery order was issued on December 15, 2025, with an ultimate completion date of December 16, 2025. The contract is performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that authorizes the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract portfolio demonstrates extensive experience delivering brand-name and generic medications, specialty pharmaceuticals, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for Cosentyx, a specialty immunosuppressant medication used in the treatment of autoimmune conditions, reflects the company's role in ensuring the availability of essential pharmaceutical products for military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FY5MB?
SPE2DR26FY5MB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DR26FY5MB worth?
The government has obligated $34,033 on SPE2DR26FY5MB.
Is contract SPE2DR26FY5MB an order under another contract?
Yes. SPE2DR26FY5MB is a delivery order under SPE2DR25D1006, an indefinite delivery contract.
Was contract SPE2DR26FY5MB competed?
The extent of competition for SPE2DR26FY5MB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award